EUVIMEDEUVIMED entdecken
Crossref

Inhibitory Immune Checkpoints Predict 7-Day, In-Hospital, and 1-Year Mortality of Internal Medicine Patients Admitted With Bacterial Sepsis

Filippo Mearelli iD, Alessio Nunnari, Annalisa Rombini, Federica Chitti, Francesca Spagnol, Chiara Casarsa, Giulia Bolzan, Ilaria Martini, Anna Marinelli, Stefania Rizzo, Cristiana Teso, Alessandra Macor und 11 weitere

The Journal of Infectious Diseases · 17.03.2025 · 231 (3) · 706-715

DOI: 10.1093/infdis/jiae370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 23.07.2024. Verfasst von Filippo Mearelli und 22 weiteren Autor:innen. Beteiligte Einrichtung: Clinica Medica, Dipartimento Scienze Mediche, Chirurgiche e della Salute, Università di Trieste, Trieste, Italy. Hauptthemen laut MEDLINE: Sepsis, Interleukin-1 Receptor-Associated Kinases, Galectin 1, Bacterial Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis is a life-threatening syndrome with complex pathophysiology and great clinical heterogeneity, which complicates the delivery of personalized therapies. Our goal was to demonstrate that some biomarkers identified as regulatory immune checkpoints in preclinical studies could guide the stratification of patients with sepsis into subgroups with shared characteristics of immune response or survival outcomes.

Methods

We assayed the soluble counterparts of 12 biomarkers of immune response in 113 internal medicine patients with bacterial sepsis.

Results

IL-1 receptor-associated kinase M (IRAK-M) exhibited the highest hazard ratios (HRs) for increased 7-day (1.94; 95% confidence interval [CI], 1.17–3.20) and 30-day mortality (1.61; 95% CI, 1.14–2.28). HRs of IRAK-M and galectin-1 for predicting 1-year mortality were 1.52 (95% CI, 1.20–1.92) and 1.64 (95% CI, 1.13–2.36), respectively. Patients with elevated serum levels of IRAK-M and galectin-1 had clinical traits of immune suppression and low survival rates.

Conclusions

Two inhibitory immune checkpoint biomarkers (IRAK-M and galectin-1) helped identify 3 distinct sepsis phenotypes with distinct prognoses. These biomarkers shed light on the interplay between immune dysfunction and prognosis in patients with bacterial sepsis and may prove to be useful prognostic markers, therapeutic targets, and biochemical markers for targeted enrollment in therapeutic trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisInterleukin-1 Receptor-Associated KinasesGalectin 1Bacterial InfectionsHumansMaleFemaleBiomarkersAgedMiddle AgedInternal MedicineHospital MortalityPrognosisAged, 80 and over

Stichwörter der Autor:innen

IRAK-Mbiomarkersgalectin-1immune paralysissepsis

Substanzen

BiomarkersInterleukin-1 Receptor-Associated KinasesGalectin 1

Autor:innen und Institutionen

  • Clinica Medica, Dipartimento Scienze Mediche, Chirurgiche e della Salute, Università di Trieste, Trieste, Italy.
  • Unità di Biostatistica, Dipartimento di Scienze Mediche, Università di Trieste, Trieste, Italy.
  • Clinica Malattie Infettive, Dipartimento di Area Medica, Università di Udine, Udine, Italy.
  • Microbiologia e Virologia, Dipartimento e Attivitá Integrata di Medicina dei Servizi, Trieste, Italy.
  • Clinica Malattie Infettive, Dipartimento Scienze Mediche, Chirurgiche e della Salute, Università di Trieste, Trieste, Italy.
  • Clinica di Anestesia e Rianimazione Udine, Dipartimento di Anestesia e Terapia Intensiva, Università di Udine, Udine, Italy.

ORCID-Profile: Filippo Mearelli

Zitieren

APA

Mearelli, F., Nunnari, A., Rombini, A., Chitti, F., Spagnol, F., Casarsa, C., Bolzan, G., Martini, I., Marinelli, A., Rizzo, S., Teso, C., Macor, A., Fiotti, N., Barbati, G., Tascini, C., Costantino, V., Di Bella, S., Di Girolamo, F. G., Bove, T., …, & Biolo, G. (2025). Inhibitory Immune Checkpoints Predict 7-Day, In-Hospital, and 1-Year Mortality of Internal Medicine Patients Admitted With Bacterial Sepsis. The Journal of Infectious Diseases, 231(3), 706-715. https://doi.org/10.1093/infdis/jiae370

Vancouver

Mearelli F, Nunnari A, Rombini A, Chitti F, Spagnol F, Casarsa C, et al. Inhibitory Immune Checkpoints Predict 7-Day, In-Hospital, and 1-Year Mortality of Internal Medicine Patients Admitted With Bacterial Sepsis. The Journal of Infectious Diseases. 2025;231(3):706-715. doi:10.1093/infdis/jiae370

BibTeX
@article{Mearelli2025,
  author = {Mearelli, Filippo and Nunnari, Alessio and Rombini, Annalisa and Chitti, Federica and Spagnol, Francesca and Casarsa, Chiara and Bolzan, Giulia and Martini, Ilaria and Marinelli, Anna and Rizzo, Stefania and Teso, Cristiana and Macor, Alessandra and Fiotti, Nicola and Barbati, Giulia and Tascini, Carlo and Costantino, Venera and Di Bella, Stefano and Di Girolamo, Filippo Giorgio and Bove, Tiziana and Orso, Daniele and Berlot, Giorgio and Klompas, Michael and Biolo, Gianni},
  title = {Inhibitory Immune Checkpoints Predict 7-Day, In-Hospital, and 1-Year Mortality of Internal Medicine Patients Admitted With Bacterial Sepsis},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {3},
  pages = {706--715},
  doi = {10.1093/infdis/jiae370}
}
Kostenlos starten →